KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis - Lohinai, Z; Klikovits, T; Moldvay, J (Sci Rep, 2017)
, et al.